Nanoparticles and the brain: Cause for concern?

Journal of Nanoscience and Nanotechnology

Volumn 9, Issue 8, 2009, Pages 4996-5007

  Oberdörster, Günter ^a   Elder, Alison ^a   Rinderknecht, Amber ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Brain; Inhalation; Nanoparticle; Neurodegeneration; Translocation

Indexed keywords

ADVERSE EFFECT; AMBIENT AIR; BIOKINETICS; BIOLOGICAL ACTIVITIES; BLOOD-BRAIN BARRIER; BRAIN ANATOMY; BREATHING PATTERNS; CAUSAL RELATIONSHIPS; CENTRAL NERVOUS SYSTEMS; DIFFERENT SIZES; IN-CELL; INHALATION; NEURODEGENERATION; NEURODEGENERATIVE; NEUROTOXIC EFFECTS; PHYSICOCHEMICAL CHARACTERISTICS; PRIMARY SURFACE; REACTIVE OXYGEN SPECIES; RESPIRATORY TRACT; SENSORY NERVES; SUBCELLULAR STRUCTURE; SURFACE AREA; SURFACE COATINGS; TARGET ORGANS; TRACHEOBRONCHIAL REGION; TRAFFIC-RELATED; TRANSLOCATION; ULTRAFINE PARTICLE;

ADSORPTION; APPROXIMATION THEORY; BLOOD; CELL MEMBRANES; COATINGS; MAMMALS; NANOPARTICLES; NEURONS; OXYGEN; SURFACE CHEMISTRY;

SURFACE PROPERTIES;

NANOPARTICLE;

BRAIN; DRUG EFFECT; EXPOSURE; HUMAN; METABOLISM; REVIEW;

BRAIN; HUMANS; INHALATION EXPOSURE; NANOPARTICLES;

EID: 70350357325     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2009.GR02     Document Type: Article

References (51)

1. R. J. Adams and D. Bray, Rapid transport of foreign particles microinjected into crab axons. Nature 303, 718 (1983).
2. B. Asgharian, F. Miller, and R. P. Subramaniam, Dosimetry software to predict particle deposition in humans and rats. CIIT Activities 19, (1999).
3. P. Ball, Nanoparticles in sun creams can stress brain cells. Nature (News) (2006), http://www.nature.com/news/2006/060616/full/news060612-14.html.
4. F. A. Barrios, L. Gonzalez, R. Favila, M. E. Alonso, P. M. Salgado, R. Diaz, and J. Fernandez-Ruiz, Olfaction and neurodegeneration in HD. Neuroreport 18, 73 (2007).
5. D. Bodian and H. A. Howe, Experimental studies on intraneural spread of poliomyelitis virus. Bull. Johns Hopkins Hosp. 69, 248 (1941).
6. A. Brown, Lymphohematogenous spread of asbestos. Environ. Health Perspect. 9, 203 (1974).
7. T. Cedervall, I. Linse, S. Lindman, T. Berggård, E. Thulin, H. Nilsson, K. A. Dawson, and S. Linse, Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. PNAS 104, 2050 (2007).
8. H. S. Choi, W. Liu, P. Misra, E. Tanaka, J. P. Zimmer, B. I. Ipe, M. G. Bawendi, and J. V. Frangioni, Renal clearance of quantum dots. Nature Biotechnol. 25, 1165 (2007).
9. T. W. Clarkson, L. Friberg, G. F. Nordberg, and P. R. Sager (eds.), Biological Monitoring of Toxic Metals, Plenum Press (1988), p. 686.
10. V. L. Colvin and K. M. Kulinowski, Nanoparticles as catalysts for protein fibrillation. PNAS 104, 8679 (2007).
11. 198Au from nasal mucous membrane into cerebrospinal fluid. Acta Otolaryng. 70, 58 (1970).
12. A. J. De Lorenzo, The olfactory neuron and the blood-brain barrier. Taste and Smell in Vertebrates, edited by G. Wolstenholme and J. Knight, Churchill, London (1970), pp. 151-176.
13. R. L. Doty, The olfactory vector hypothesis of neurodegenerative disease: Is it viable? Ann. Neurol. 63, 7 (2008).
14. K. E. Driscoll, D. L. Costa, G. Hatch, R. Henderson, G. Oberdörster, H. Salem, and R. B. Schlesinger, Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: Uses and limitations. Toxicol. Sci. 55, 24 (2000).
15. EPA, EPA Health Criteria Document: Air Quality Criteria for Particulate Matter, EPA/600/P-99/002aF, October (2004).
16. A. Elder, R. Gelein, V. Silva, T. Feikert, L. Opanashuk, J. Carter, R. Potter, A. Maynard, Y. Ito, J. Finkelstein, and G. Oberdörster, Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ. Health Perspect. 114, 1172 (2006).
17. A. Elder, N. Corson, R. Gelein, P. Mercer, A. Rinderknecht, J. Finkelstein, and G. Oberdörster, Tissue Distribution in Rats of Surface-Modified Quantum Dots Following Lung or Intravenous Exposure. Am. J. Respir. Crit. Care Med. 175, A246 (2007).
18. J. Eide, B. Gylseth, and V. Skaug, Silicotic lesions of the bone marrow: Histopathology and microanalysis. Histopathology 8, 693 (1984).
19. M. Ehrenberg and J. L. McGrath, Binding between particles and proteins in extracts: Implications for microrheology and toxicity. Acta Biomaterialia 1, 305 (2005).
20. Y. Finkelstein, D. Milatovic, and M. Aschner, Modulation of cholinergic systems by manganese. NeuroToxicology 28, 1003 (2007).
21. ICRP, Human respiratory model for radiological protection. Ann. ICRP 24, 1 (1994).
22. L. Illum, Transport of drugs from the nasal cavity to the central nervous system. Europ. J. Pharmacol. Sci. 11, 1 (2000).
23. J. Jiang, G. Oberdörster, and P. Biswas, Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J. Nanopart. Res. 11, 77 (2009).
24. C. J. Johnston, J. N. Finkelstein, P. Mercer, N. Corson, R. Gelein, and G. Oberdörster, Pulmonary effects induced by ultrafine PTFE particles. Toxicol. Appl. Pharmacol. 168, 208 (2000).
25. T. Kovács, Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders. Ageing Res. Rev. 3, 215 (2004).
26. J. Kreuter, Nanoparticles-A historical perspective. Int. J. Pharmaceut. 331, 1 (2007).
27. W. G. Kreyling, M. Semmler, F. Erbe, P. Mayer, S. Takenaka, H. Schulz, G. Oberdörster, and A. Ziesenis, Ultrafine insoluble iridium particles are negligibly translocated from lung epithelium to extrapulmonary organs. J. Tox. Environ. Health 65, 1513 (2002).
28. L. Lacerda, A. Soundararajan, R. Singh, G. Pastorin, K. T. Al-Jamal, J. Turton, P. Frederik, M. A. Herrero, S. Li, A. Bao, D. Emfietzoglou, S. Mather, W. T. Phillips, M. Prato, A. Bianco, B. Goins, and K. Kostarelos, Dynamic imaging of functionalized multi-walled carbon nanotube systemic circulation and urinary excretion. Adv. Mater. 20, 225 (2008).
29. J. Lademann, H. Richter, A. Teichmann, N. Otberg, U. Blume-Peytavi, J. Luengo, B. Weiß, U. F. Schaefer, C.-M. Lehr, R. Wepf, and W. Sterry, Nanoparticles-An efficient carrier for drug delivery into the hair follicles. Europ. J. Pharm. Biopharm. 66, 159 (2007).
30. S. Linse, C. Cabaleiro-Lago, W.-F. Xue, I. Lynch, S. Lindman, E. Thulin, S. E. Radford, and K. A. Dawson, Nucleation of protein fibrillation by nanoparticles. PNAS 104, 8691 (2007).
31. L. Liu, K. Guo, J. Lu, S. S. Venkatraman, D. Luo, K. C. Ng, E.-A. Ling, S. Moochhala, and Y.-Y. Yang, Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials 29, 1509 (2008).
32. T. C. Long, N. Saleh, R. D. Tilton, G. V. Lowry, and B. Veronesi, Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV12): Implications for nanoparticle neurotoxicity. Environ. Sci. Technol. 40, 4346 (2006).
33. J. R. Minkel, The truth about nanopollution. Popular Science 270, 62 (2007).
34. P. J. Moberg and R. L. Doty, Olfactory function in Huntington's disease patients and at-risk offspring. Int. J. Neurosci. 89, 133 (1997).
35. P. E. Morrow, Contemporary issues in toxicology-Dust overloading of the lungs: Update and appraisal. Toxicol. Appl. Pharmacol. 113, 1 (1992).
36. R. H. Müller and C. M. Keck, Drug delivery to the brain realization by novel drug carriers. J. Nanosci. Nanotechnol. 4, 471 (2004).
37. G. Oberdörster, Z. Sharp, V. Atudorei, A. Elder, R. Gelein, W. Kreyling, and C. Cox, Translocation of inhaled ultrafine particles to the brain. Inhalat. Toxicol. 16, 437 (2004).
38. G. Oberdörster, E. Oberdörster, and J. Oberdörster, Invited Review: Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113, 823 (2005).
39. A. Orosz, I. Foldes, C. Kosa, and G. Toth, Radioactive isotope studies of the connection between the lymph circulation of the nasal mucosa, the cranial cavity and cerebrospinal fluid. Acta Physiologica Academiae Scientiarum Hungaricae 2, 75 (1957).
40. A. Rinderknecht, A. Elder, R. Prud'homme, M. Gindy, J. Harkema, and G. Oberdörster, Surface functionalization affects the role of nanoparticle disposition. Am. J. Respir. Crit. Care Med. 175, A246 (2007).
41. M. B. Segal, The choroid plexuses and the barriers between the blood and the cerebrospinal fluid. Cell. and Mol. Neurobiol. 20, 183 (2000).
42. M. Semmler, J. Seitz, F. Erbe, P. Mayer, J. Heyder, G. Oberdörster, and W. G. Kreyling, Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung including transient translocation into secondary organs. Inhalat. Toxicol. 16, 453 (2004).
43. M. Semmler-Behnke, S. Takenaka, S. Fertsch, A. Wenk, J. Seitz, P. Mayer, G. Oberdörster, and W. G. Kreyling, Efficient elimination of inhaled nanoparticles from the alveolar region: Evidence for interstitial uptake and subsequent re-entrainment onto airways epithelia. Environ. Health Perspect. 115, 728 (2007).
44. H. S. Sharma, Nanoneuroscience: Emerging concepts on nanoneurotoxicity and nanoneuroprotection. Nanomedicine 2, 753 (2007).
45. R. Singh, D. Pantarotto, L. Lacerda, G. Pastorin, C. Klumpp, M. Prato, A. Bianco, and K. Kostarelos, Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. PNAS 103, 3357 (2006).
46. R. E. Slavin, J. L. Swedo, D. Brandes, J. C. Gonzalez-Vitale, and A. Osornio-Vargas, Extrapulmonary silicosis: A clinical, morphologic, and ultrastructural study. Hum. Pathol. 16, 393 (1985).
47. 2 nanoparticles. Toxicology 254, 82 (2008a).
48. 2 nanoparticles in the anatase and rutile crystal phases. Toxicol. Letter 183, 72 (2008b).
49. L. E. Yu, L.-Y. L. Yung, C.-N. Ong, Y.-L. Tan, K. S. Balasubramaniam, D. Hartono, G. Shui, M. R. Wenk, and W.-Y. Ong, Translocation and effects of gold nanoparticles after inhalation exposure in rats. Nantoxicology 1, 235 (2007).
50. Q. Zhang, L. Zha, Y. Zhang, W. Jiang, W. Lu, Z. Shi, X. Jiang, and S. Fu, The brain targeting efficiency following nasally applied MPEG-PLA nanoparticles in rats. J. Drug Targeting 14, 281 (2006).
51. T. Kato, T. Yashiro, Y. Murata, D. C. Herbert, K. Oshikawa, M. Bando, S. Ohno, and Y. Sugiyama. Evidence that exogenous substances can be phagocytized by alveolar epithelial cells and transported into blood capillaries. Cell Tiss. Res. 311, 47 (2003).